MERRIMACK PHARMACEUTICALS - ASSETS
Merrimack Pharmaceuticals - Assets (irinotecan liposome injection) for the treatment of patients with metastatic adenocarcinoma of pancreas.
MERRIMACK PHARMACEUTICALS - ASSETS
Industry:
Biotechnology
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
More informations about "Merrimack Pharmaceuticals - Assets"
Merrimack - Crunchbase Company Profile & Funding
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer. View contacts for Merrimack to access new leads and connect with decision-makers. …See details»
Merrimack Pharmaceuticals - Wikipedia
Merrimack Pharmaceuticals, Inc. is a pharmaceutical company based in Cambridge, Massachusetts, United States. They specialize in developing drugs for the treatment of cancer. Merrimack's first FDA-approved drug was approved in 2015; Onivyde, a liposome encapsulated version of irinotecan is used for treating pancreatic adenocarcinoma. …See details»
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
Jan 9, 2017 · Ipsen (Euronext: IPN; ADR: IPSEY) today announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals …See details»
Merrimack Pharmaceuticals (MACK) - Total assets
According to Merrimack Pharmaceuticals's latest financial reports the company's total assets are ₹20.61 Billion. A company’s total assets is the sum of all current and non-current assets, such …See details»
Merrimack Pharmaceuticals total assets 2023 - Statista
Nov 1, 2024 · The total assets of Merrimack Pharmaceuticals with headquarters in the United States amounted to 19.19 million U.S. dollars in 2023. The reported fiscal year ends on …See details»
Merrimack Pharmaceuticals Inc - AnnualReports.com
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.See details»
Merrimack - Funding, Financials, Valuation & Investors - Crunchbase
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.See details»
Governance Merrimack Pharmaceuticals - MarketScreener.com
Dec 31, 2014 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential …See details»
Merrimack Pharmaceuticals, Inc. (MACK) - Yahoo Finance Canada
See the company profile for Merrimack Pharmaceuticals, Inc. (MACK) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Governance Merrimack Pharmaceuticals Börse Stuttgart
Find the composition of the Board of Directors of Merrimack Pharmaceuticals, Inc. (Börse Stuttgart Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
Merrimack Pharmaceuticals - Products, Competitors, Financials ...
Merrimack Pharmaceuticals is a biopharmaceutical company that focuses on the development of targeted solutions for cancer care. Use the CB Insights Platform to explore Merrimack …See details»
Merrimack Pharmaceuticals, Inc. Total Assets 2012-2024 | MACK
Merrimack Pharmaceuticals, Inc. total assets from 2012 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.See details»
Merrimack Reports Full Year 2021 Financial Results
Mar 9, 2022 · Merrimack reported a gain on sale of assets for the year ended December 31, 2021 of $0.1 million compared to $2.1 million for the same period in 2020. General and …See details»
Merrimack Reports Third Quarter 2021 Financial Results
Nov 4, 2021 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent …See details»
Merrimack Pharmaceuticals, Inc. Announces Stockholder Approval …
May 10, 2024 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company based in Cambridge, Massachusetts that is entitled to receive up to $450.0 million in contingent …See details»
Merrimack Pharmaceuticals, Inc. Total Current Assets 2012-2024
Merrimack Pharmaceuticals, Inc. total current assets from 2012 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a …See details»
Merrimack Pharmaceuticals Announces Notification of Plan to …
CAMBRIDGE, Mass., April 30, 2024 -- (BUSINESS WIRE)--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has filed notice with …See details»
Merrimack Pharmaceuticals, Inc. (A) - Harvard Business School
In 2006, Merrimack Pharmaceuticals was a fast-growing biotechnology company. Its leadership team was divided over whether to keep R&D organized in functional departments or transition …See details»
Merrimack Pharmaceuticals Stock - MarketScreener.com
May 17, 2024 · Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential …See details»
Merrimack - Contacts, Employees, Board Members, Advisors
Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.See details»